"Apollon Jamaica is again seeing patients at our pre-COVID levels," said Stephen Barnhill.
Apollon Formularies Plc (AQSE:APOL) told investors it has reopened its medical cannabis dispensary and treatment centre in Jamaica following certification for COVID-19 health and safety.
The company, in a statement, noted that Jamaica’s Tourism Product Development Company Ltd (TPDCo), an agent for the government, recently performed a COVID-19 compliance assessment of the facility in Negril.
"We are very proud of our Jamaican team for successfully passing all requirements leading to this certification,” said Stephen Barnhill, group chief executive.
“Since receiving this government required certification, Apollon Jamaica is again seeing patients at our pre-COVID levels.